| ASO | Antisense Oligonucleotide |
| CMC | Chemistry, Manufacturing, and Controls |
| CTiD | Clinical-Trials-in-a-Dish |
| DMD | Duchenne Muscular Dystrophy |
| EU | European Union |
| hATTR | Hereditary Transthyretin-Mediated Amyloidosis |
| IND | Investigational New Drug |
| iPSC | Induced Pluripotent Stem Cell |
| NAM | New Approach Methodology |
| PK/PD | Pharmacokinetics/Pharmacodynamics |
| siRNA | Small Interfering RNA |
| SMA | Spinal Muscular Atrophy |
| U.S. FDA | United States Food and Drug Administration |
| WHO | World Health Organization |